Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension
- 1 October 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 291 (4), L694-L702
- https://doi.org/10.1152/ajplung.00119.2006
Abstract
Familial forms of human pulmonary arterial hypertension (FPAH) have been linked to mutations in bone morphogenetic protein (BMP) type II receptors (BMPR2s), yet the downstream targets of these receptors remain obscure. Here we show that pulmonary vascular lesions from patients harboring BMPR2 mutations express high levels of tenascin-C (TN-C), an extracellular matrix glycoprotein that promotes pulmonary artery (PA) smooth muscle cell (SMC) proliferation. To begin to define how TN-C is regulated, PA SMCs were cultured from normal subjects and from those with FPAH due to BMPR2 mutations. FPAH SMCs expressed higher levels of TN-C than normal SMCs. Similarly, expression of Prx1, a factor that drives TN-C transcription, was elevated in FPAH vascular lesions and SMCs derived thereof. Furthermore, Prx1 and TN-C promoter activities were significantly higher in FPAH vs. normal SMCs. To delineate how BMPR2s control TN-C, we focused on receptor (R)-Smads, downstream effectors activated by wild-type BMPR2s. Nuclear localization and phosphorylation of R-Smads was greater in normal vs. FPAH SMCs. As well, indirect blockade of R-Smad signaling with a kinase-deficient BMP receptor Ib upregulated TN-C in normal SMCs. Because ERK1/2 MAPKs inhibit the transcriptional activity of R-Smads, and because ERK1/2 promotes TN-C transcription, we determined whether ERK1/2 inhibits R-Smad signaling in FPAH SMCs and whether this activity is required for TN-C transcription. Indeed, ERK1/2 activity was greater in FPAH SMCs, and inhibition of ERK1/2 resulted in nuclear localization of R-Smads and inhibition of TN-C. These studies define a novel signaling network relevant to PAH underscored by BMPR2 mutations.Keywords
This publication has 42 references indexed in Scilit:
- Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1The Journal of cell biology, 2003
- Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutationEuropean Respiratory Journal, 2003
- BMP signaling is required for septation of the outflow tract of the mammalian heartDevelopment, 2003
- 5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neuronsNeuroscience, 2001
- Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II GeneAmerican Journal of Human Genetics, 2000
- BMP Type II Receptor Is Required for Gastrulation and Early Development of Mouse EmbryosDevelopmental Biology, 2000
- Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular diseaseJCI Insight, 2000
- Regression of Hypertrophied Rat Pulmonary Arteries in Organ Culture Is Associated With Suppression of Proteolytic Activity, Inhibition of Tenascin-C, and Smooth Muscle Cell ApoptosisCirculation Research, 1999
- Extracellular matrix and integrin signalling: the shape of things to comeBiochemical Journal, 1999
- Abnormal Behavior and Neurotransmissions of Tenascin Gene Knockout MouseBiochemical and Biophysical Research Communications, 1996